This private equity firm with offices in Rowayton consists of members and principals with backgrounds in finance, consulting, and/or the health sciences. They seek out, qualify and invest in companies holding patents and developing products in the fields of biotechnology, specialty pharmaceuticals and medical devices. The investment portfolio consists of around 20 closely-help and publicly traded companies in the advanced stages of bringing to market health-related products such as drugs for pain, anti-infectives, blood glucose monitoring devices and surgical systems.